Integrative genomic approaches identify IKBKE as a breast cancer oncogene
- PMID: 17574021
- DOI: 10.1016/j.cell.2007.03.052
Integrative genomic approaches identify IKBKE as a breast cancer oncogene
Abstract
The karyotypic chaos exhibited by human epithelial cancers complicates efforts to identify mutations critical for malignant transformation. Here we integrate complementary genomic approaches to identify human oncogenes. We show that activation of the ERK and phosphatidylinositol 3-kinase (PI3K) signaling pathways cooperate to transform human cells. Using a library of activated kinases, we identify several kinases that replace PI3K signaling and render cells tumorigenic. Whole genome structural analyses reveal that one of these kinases, IKBKE (IKKepsilon), is amplified and overexpressed in breast cancer cell lines and patient-derived tumors. Suppression of IKKepsilon expression in breast cancer cell lines that harbor IKBKE amplifications induces cell death. IKKepsilon activates the nuclear factor-kappaB (NF-kappaB) pathway in both cell lines and breast cancers. These observations suggest a mechanism for NF-kappaB activation in breast cancer, implicate the NF-kappaB pathway as a downstream mediator of PI3K, and provide a framework for integrated genomic approaches in oncogene discovery.
Comment in
-
All roads lead to IKKepsilon.Cell. 2007 Jun 15;129(6):1043-5. doi: 10.1016/j.cell.2007.05.048. Cell. 2007. PMID: 17574017
Similar articles
-
All roads lead to IKKepsilon.Cell. 2007 Jun 15;129(6):1043-5. doi: 10.1016/j.cell.2007.05.048. Cell. 2007. PMID: 17574017
-
Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors.J Mammary Gland Biol Neoplasia. 2018 Sep;23(3):177-187. doi: 10.1007/s10911-018-9404-4. Epub 2018 Jul 21. J Mammary Gland Biol Neoplasia. 2018. PMID: 30032344
-
Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.Cancer Res. 2005 Dec 15;65(24):11375-83. doi: 10.1158/0008-5472.CAN-05-1602. Cancer Res. 2005. PMID: 16357145
-
Regulation and function of IKK and IKK-related kinases.Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13. Sci STKE. 2006. PMID: 17047224 Review.
-
Advances in IKBKE as a potential target for cancer therapy.Cancer Med. 2020 Jan;9(1):247-258. doi: 10.1002/cam4.2678. Epub 2019 Nov 15. Cancer Med. 2020. PMID: 31733040 Free PMC article. Review.
Cited by
-
Narrowing the focus: a toolkit to systematically connect oncogenic signaling pathways with cancer phenotypes.Genes Cancer. 2016 Jul;7(7-8):218-228. doi: 10.18632/genesandcancer.112. Genes Cancer. 2016. PMID: 27738492 Free PMC article. Review.
-
Altered Body Weight Regulation in CK1ε Null and tau Mutant Mice on Regular Chow and High Fat Diets.Genet Res Int. 2016;2016:4973242. doi: 10.1155/2016/4973242. Epub 2016 Apr 6. Genet Res Int. 2016. PMID: 27144030 Free PMC article.
-
New insight into the oncogenic mechanism of the retroviral oncoprotein Tax.Protein Cell. 2012 Aug;3(8):581-9. doi: 10.1007/s13238-012-2047-0. Epub 2012 Jul 21. Protein Cell. 2012. PMID: 22865346 Free PMC article. Review.
-
Pentagalloyl glucose inhibits TNF-α-activated CXCL1/GRO-α expression and induces apoptosis-related genes in triple-negative breast cancer cells.Sci Rep. 2021 Mar 11;11(1):5649. doi: 10.1038/s41598-021-85090-z. Sci Rep. 2021. PMID: 33707603 Free PMC article.
-
IKK-ε coordinates invasion and metastasis of ovarian cancer.Cancer Res. 2012 Nov 1;72(21):5494-504. doi: 10.1158/0008-5472.CAN-11-3993. Epub 2012 Aug 31. Cancer Res. 2012. PMID: 22942254 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- CA015607/CA/NCI NIH HHS/United States
- R01 CA094074-01A1/CA/NCI NIH HHS/United States
- CA30002/CA/NCI NIH HHS/United States
- P50 CA089393-080014/CA/NCI NIH HHS/United States
- CA89021/CA/NCI NIH HHS/United States
- P50 CA089393/CA/NCI NIH HHS/United States
- R01 CA094074-05/CA/NCI NIH HHS/United States
- P50 CA089393-070014/CA/NCI NIH HHS/United States
- R01 CA094074-02/CA/NCI NIH HHS/United States
- P50 CA089393-060014/CA/NCI NIH HHS/United States
- R01 CA094074-04/CA/NCI NIH HHS/United States
- R01 CA094074-03/CA/NCI NIH HHS/United States
- P50 CA112962/CA/NCI NIH HHS/United States
- R01 CA094074/CA/NCI NIH HHS/United States
- K01 CA94223/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous